SCHEMBL23212921

SCHEMBL23212921

CCOC(=O)CC(c1cc(F)ccc1Br)C(C(=O)OCC)C(=O)OCC.O=C(O)CC(CC(=O)O)c1cc(F)ccc1Br

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
PKM P14618 1/20 0.34
PTGFR P43088 3/20 0.33
KDM4E B2RXH2 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
FFAR1 O14842 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
PRNP P04156 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210058 0.92 MAPT (0.36) ALDH1A1TSHRPKMMEN1KMT2A
SCHEMBL23212933 0.91 MAPT (0.35) ALDH1A1TSHRPKMMEN1KMT2A
SCHEMBL29619715 0.79 PKM (0.45) PKMPTGFRFFAR1FFAR4
SCHEMBL23210225 0.79 PKM (0.45) PKMPTGFRFFAR1FFAR4
SCHEMBL23210101 0.75 TSHR (0.45) ALDH1A1TSHRMEN1KMT2ACYP2C9
SCHEMBL18431018 0.75 HPGD (0.41) ALDH1A1TSHRKDM4EALOX15HSD17B10
SCHEMBL7450364 0.70 MAPT (0.43) ALDH1A1TSHRFFAR1MEN1KMT2A
SCHEMBL1526990 0.69 MAPT (0.38) ALDH1A1TSHRPKMKDM4EMEN1
SCHEMBL1526991 0.69 MAPT (0.38) ALDH1A1TSHRPKMKDM4EMEN1
SCHEMBL12603183 0.69 APLNR (0.41) ALDH1A1TSHRPKMKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041389-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Novartis AG (CH) 2022-08-17 EP disclosed
EP-4041737-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Novartis AG (CH) 2022-08-17 EP disclosed
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed
WO-2021070090-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed